Right Ventricular Failure | NEJM Skip to main content NEJM Group Follow Us Facebook Twitter
Instagram YouTube LinkedIn Prepare to become a physician, build your knowledge, lead a …

The pathogenesis and clinical features of diabetic cardiomyopathy have been well-studied
in the past decade, but effective approaches to prevent and treat this disease are limited …

Diabetic cardiomyopathy (DCM) is a cardiac dysfunction which affects approximately 12% of
diabetic patients, leading to overt heart failure and death. However, there is not an efficient …

Diabetic cardiomyopathy (DCM) is a pathophysiological condition of cardiac structure and
function changes in diabetic patients without coronary artery disease, hypertension, and …

Heart failure in patients with diabetes has been recognised since 1876. 1 The
cardiovascular harm of thiazolidinediones shone the 21st century spotlight on the interaction …

Accumulating evidence shows that metformin is an insulin-sensitizing antidiabetic drug
widely used in the treatment of type 2 diabetes mellitus (T2DM), which can exert favorable …

Diabetes mellitus is a chronic, progressive, incompletely understood metabolic disorder
whose prevalence has been increasing steadily worldwide. Even though little attention has …

Background—Individuals with diabetes mellitus and pre–diabetes mellitus are at particularly
high risk of incident heart failure or death, even after accounting for known confounders …

Background: Diabetes mellitus (DM) is associated with increased risk of cardiovascular
disease. Detection of early cardiac changes before manifest disease develops is important …

Backgrounds The role of right ventricular (RV) and atrial (RA) structure and function, in the
increased heart failure risk in (pre) diabetes is incompletely understood. The purpose of this …